I-Mel binding is detected, inmice; pertussis toxin still blocks melatonin-induced cluding the SCN ; Weaver and phase shifts in Mel 1a receptor-deficient mice. The other Roca et al., 1996) . This has led to the melatonin receptor subtype, the Mel 1b receptor, is hypothesis that this receptor subtype mediates the maexpressed in mouse SCN, implicating it in the phasejor neurobiological actions of melatonin in mammals, shifting response. The results provide a molecular basis for two distinct, mechanistically separable effects including those on SCN function . of melatonin on SCN physiology.
Expression of the mammalian Mel 1b receptor gene has been more difficult to evaluate. Mel 1b receptor mRNA has not been detected in any brain region by conventional in Introduction situ hybridization methods our unpublished data) . Its expression is detectable in human The suprachiasmatic nuclei (SCN) are the site of a masretina and brain by reverse transcription-polymerase ter clock in mammalian brain generating circadian chain reaction (RT-PCR; . rhythms in physiology and behavior (reviewed by Klein Lack of subtype-selective drugs for melatonin recepet al., 1991) . Normally, the light-dark cycle resets (entors has made it impossible to critically evaluate the trains) the SCN clock and the circadian rhythms it drives contribution of each of the two receptor subtypes to to the 24 hr day. Entrainment ensures that circadian melatonin effects in the SCN. We now test the hypotherhythms are expressed in correct relationship to each sis that the Mel1a receptor mediates both acute neuronal other and to the 24 hr day, conferring temporal order inhibition and the phase-shifting effects of melatonin on among biological processes.
SCN function by using mice with targeted disruption of Melatonin, the principal hormone of the vertebrate the Mel 1a receptor. Although the data show that the Mel 1a pineal gland, appears to elicit two effects on SCN funcreceptor is essential for melatonin-induced acute inhibition. First, the hormone can acutely inhibit SCN neuronal tion of SCN neuronal firing, we were surprised to find firing (Mason and Brooks, 1988; Shibata et al., 1989;  that this receptor subtype is not essential for the phase- Stehle et al., 1989) . This effect may be important for shifting effects of melatonin in mice. These results 1) defining SCN sensitivity to phase-shifting (entraining) substantiate the physiological significance of the acute stimuli. Second, melatonin itself can entrain mammalian inhibitory effect of melatonin on biological clock function circadian rhythms (Cassone, 1990; Lewy et al., 1992;  and 2) provide a molecular basis for two distinct effects Benloucif and Dubocovich, 1996) and appears to act in concert with light to hold circadian rhythms in phase of melatonin on SCN physiology. Genomic DNA was digested with EcoRV and probed with a radiolabeled 3Ј probe (1 kb). The wild-type allele produces an 18 kb hybridizing product, while the disrupted allele produces a 7 kb hybridizing product.
(C) PCR analysis of genomic DNA from wild-type, heterozygous, and homozygous mutant mice. Genomic DNA was subject to PCR using a cocktail of primers A, B, and C (primer positions depicted in [A] ). The wild-type allele (primers A-B) produces a 480 bp product, while the disrupted allele (primers A-C) produces a 240 bp product.
Results chimeras were mated to C57BL/6 mice. Germline transmission was obtained from both clones. Offspring of heterozygous crosses were genotyped by either SouthTargeted Disruption of the Mel1a Receptor The mouse Mel 1a receptor gene is composed of two ern blotting or PCR (Figure 1 ). The Mel 1a receptor gene mutation appears to have no exons divided by a large (Ͼ13 kb) intron . Exon 1 encodes the 5Ј untranslated region and effect on survival. Of the first 501 pups born from breeding heterozygotes, 131 (26.2%) were homozygous for the coding region through the first cytoplasmic loop, while exon 2 encodes the rest of the coding region and the receptor mutation. Within each of the two ES cell lines generated, the ratio of genotypes from breeding the 3Ј untranslated region. A targeting vector was constructed from a 15 kb genomic clone (from a 129/Sv heterozygotes did not differ from the expected Mendelian ratio of 1:2:1 (p Ͼ 0.05, chi-square test). Both male genomic library) by replacing exon 1 with a cassette containing a neomycin resistance gene under control and female homozygous mutants were fertile. Because the Mel1a receptor is normally expressed in of the phosphoglycerate kinase 1 promoter (PGKNeo; Figure 1) ; deletion of exon 1 should inactivate the Mel1a the SCN Roca et al., 1996) and thus potentially involved in biological responses of the receptor gene (see below). The resultant targeting vector consists of ‫5.11ف‬ kb of genomic DNA 5Ј of the PGKNeo circadian clock, we assessed circadian function in homozygous mutants. No significant abnormalities in circassette and ‫5.3ف‬ kb of genomic DNA at the 3Ј end (Figure 1 ). The targeting vector was transfected into cadian function were detected in homozygous mutant mice. The mutant mice exhibited robust circadian 129/Sv J1 embryonic stem (ES) cells, and homologous recombination was assessed by Southern blot analysis rhythms (of appropriate phase and amplitude) in wheelrunning behavior that entrained to the light-dark cycle with probes flanking the targeted DNA (data not shown). Two clones carrying the targeted allele were microin-(data not shown). Assessment of the period (cycle) length of the activity rhythm in constant darkness jected into C57BL/6 mouse blastocysts, and resulting showed no significant difference between homozygous These mice exhibited a very restricted pattern of 125 IMel binding in brain, similar to that described in other mutant mice (period length ϭ 23.47 Ϯ 0.10 hr; mean Ϯ rodents . The most intense specific SEM; n ϭ 12) and wild types (23.49 Ϯ 0.08 hr; n ϭ 15 ).
binding was observed in the hypophyseal pars tuberalis It is important to mention that neither 129/Sv or (PT) of the pituitary (Figure 2 ). The SCN, paraventricular C57BL/6 mice make melatonin; these strains appear to nucleus of the thalamus (PVT), and parabigeminal nuhave a genetic defect in pineal melatonin biosynthesis cleus also contained a high level of specific 125 I-Mel (Goto et al., 1989) . Nonetheless, we show (see below) binding ( Figure 2) . A moderate level of specific binding that wild-type mice of 129/Sv/C57BL/6 hybrid genetic was present in the anterior hypothalamus (anterior and background have a normal complement of high affinity lateral to the SCN), in several thalamic nuclei (the reunmelatonin receptors as assessed by 125 I-Mel in vitro autoiens nucleus, the nucleus of the stria medullaris, and radiography. In addition, as described in subsequent portions of the paratenial and anterodorsal nuclei), and sections, the SCN of these mice exhibit robust rein the caudal half of the nucleus of the optic tract ( Figure  sponses to melatonin in the two in vitro assay systems 2; data not shown). Lower levels of specific 125 I-Mel bindthat we employ in our studies. Thus, we are confident ing were detected in the medial portion of the accumthat studies of receptor and effector mechanisms inbens nucleus, in the central nucleus of the amygdala, volved in the SCN are valid in 129/Sv/C57BL/6 mice.
and at the lateral border of the anterior pretectal nucleus. I-Mel in vitro autoradito that previously reported for C57BL/6J mice and is ography was used. This method is the most sensitive also similar to that reported for strains of mice that make means currently available to evaluate the presence of melatonin (C3H/HeN; Siuciak et al., 1990; Roca, 1996) . high affinity melatonin receptors in individual brain nuIn marked contrast to the detection of specific 125 I-Mel clei (Cassone, 1990; Benloucif and Dubocovich, 1996) as well as the rhythm in SCN firing rate in vitro (Starkey the level of specific 125 I-Mel binding in the SCN of heterozygous mice (n ϭ 9) was 52.5% that of wild-type mice et al. McArthur et al. 1991 McArthur et al. , 1997 . Because of the large decline in firing rate between CT 9.5-11.5 (see (n ϭ 5; P ϭ 0.001, Student's t test). The ‫%05ف‬ reduction in binding in heterozygous animals suggests an effect Figure 3 ), the effects of melatonin application on firing rate were assessed relative to a separate group of slices, of gene dosage on the level of 125 I-Mel binding observed. Preliminary studies of fetal mouse brain and pituitary to which vehicle was applied at the identical time. Melatonin effects were also examined at CT 4.5-6.5 because also revealed that 125 I-Mel binding detected in these structures in wild-type mice was absent in homozygous the peak of the rhythm in multiunit activity occurs at this time, and multiunit activity is constant over this period. Mel1a receptor-mutant mice and reduced in heterozygotes. Taken together, the autoradiographic results Melatonin treatments at CT 4.5-6.5 were compared with prior vehicle treatments (at CT 4.0-4.5) of the same slice. clearly show that the engineered Mel 1a receptor gene mutation is a null allele and that Mel 1a receptors normally Circadian rhythms of firing rate were comparable in phase and amplitude between wild-type and homozyaccount for most, if not all, high affinity melatonin binding in mouse brain.
gous mutant mice ( Figure 3 ; data not shown).
Melatonin caused a consistent inhibition of multiunit activity in SCN slices from wild-type mice. When melatoTargeted Disruption of the Mel 1a Receptor Abolishes the Acute Inhibitory Effect of nin was applied at increasing concentrations (0.1, 1, 10, and 100 nM at 30 min intervals) from CT 4.5-6.5, there Melatonin on SCN Neuronal Firing We next examined the ability of melatonin to acutely was a significant, concentration-dependent inhibition of neuronal activity in slices from wild-type mice comsuppress SCN neuronal firing in wild-type and Mel1a receptor-deficient mice. For this aspect of study, multiunit pared with vehicle treatment from CT 4.0-4.5 (P ϭ 0.001, one-way ANOVA; Figures 3 and 4, upper panels). The recordings of hypothalamic slices containing SCN were used. With this system, circadian rhythms in neuronal EC50 of the melatonin-induced inhibition was 412 pM. When melatonin (0.1-100 nM) was applied from CT 9.5-firing rate can be consistently monitored for 3 days in culture (V. Gribkoff, unpublished data). The suppressive 11.5, there was also a significant inhibition of neuronal activity compared to vehicle-treated slices (p Ͻ 0.05, effect of melatonin on neuronal firing was examined at two circadian times (CT , where CT 12 is the projected one-way ANOVA; Figure 4 , lower panel), but the melatonin effect was much more variable because of the steep time of lights off in the colony room). Studies were conducted at CT 9.5-11.5 on day 1 in culture and CT 4.5-6.5 slope of the multiunit activity pattern at this time (see Figure 3 ). These results indicate that the in vitro multiunit on day 2 (Figure 3 ). CT 9.5-11.5 was examined because melatonin's ability to suppress SCN multiunit activity. At both treatment times, CT 9.5-11.5 and CT 4.5-6.5, melatonin (0.1-100 nM) was unable to significantly inhibit SCN multiunit activity in Mel 1a receptor-deficient mice, relative to vehicle treatments (p Ͼ 0.50 for each treatment time, one-way ANOVAs; Figure 3 , lower panel and Figure 4 , upper and lower panels). These results indicate that the Mel 1a receptor mediates the acute inhibitory effect of melatonin observed with SCN multiunit recordings.
Studies in wild-type C57BL/6 mice showed that physiological levels of melatonin (1 nM) also inhibit SCN multiunit activity at night at CT 18 (33.9% Ϯ 3.9% inhibition; n ϭ 8). This is important, because it is at a time when melatonin levels are normally high in the living animal (Klein, 1993) . Thus, melatonin can elicit its inhibitory effect on SCN function at a physiologically relevant time.
Targeted Disruption of the Mel 1a Receptor Modifies But Does Not Eliminate the Phase Shifting Effect of Melatonin on the SCN Firing Rhythm
The phase-shifting effects of melatonin in wild-type and Mel1a receptor-deficient mice were assessed using an in vitro assay, in which single-unit extracellular activity is monitored from SCN slices. This in vitro method was used because it is not subject to the artifactual results sometimes observed with in vivo drug treatments (Van Reeth and Turek, 1989; Hastings et al., 1992) . In addition, the melatonin-induced shifts in vitro are much larger (Cassone, 1990; McArthur et al., 1991;  The upper panel shows the effects of melatonin treatment from CT Starkey, 1996) . Moreover, studies in rats have shown 4.5-6.5 (day 2 in culture) on multiunit activity in SCN slices from that the phase-shifting effect of melatonin on the singlewild-type (ϩ/ϩ) and homozygous mutant (Ϫ/Ϫ) mice. For each slice, unit activity rhythm is a high affinity response (EC 50 Ͻ the percent inhibition of SCN firing rate induced by melatonin was determined relative to vehicle treatment at CT 4.0-4.5. Melatonin 100 pM) and that it is blocked by pertussis toxin (Starkey treatments consisted of 30 min consecutive exposures to 0.1, 1, 10, et al., 1995; McArthur et al., 1997) . These characteristics and 100 nM melatonin. All SCN slices were also treated with either are consistent with melatonin inducing phase shifts by vehicle or melatonin on day 1 in culture. There was no significant a high affinity, G protein-coupled melatonin receptor. effect of melatonin application on day 1 in culture, relative to vehicle For our in vitro studies, the phase-shifting effect of application, on the day 2 (CT 4.5-65) melatonin response data (P ϭ melatonin was examined at CT 9.5-10.5, because in 0.45), so the data sets were combined. This is because there is no significant effect of melatonin treatment on day 1 to the timing of rats and in our preliminary studies of wild-type mice, the multiunit activity peak on day 2; the broad peak of the multiunit melatonin application at this time consistently elicited activity rhythm precludes use of this assay for monitoring melatonina ‫4ف‬ hr phase advance in circadian phase (data not induced phase shifts. The genotype of the animals was not known shown). We also showed that melatonin application from until after experiments were completed and data were analyzed.
CT 5.5-6.5 to SCN slices from wild-type mice did not Each value is the mean Ϯ SEM of 7-11 slices for each genotype at elicit significant phase shifts in the electrical activity each melatonin dose. The lower panel shows the effects of melatonin treatment from CT rhythm (CT of activity peak was 6.8 Ϯ 0.3 hr; n ϭ 3; 9.5-11.5 on day 1 in culture. Melatonin treatments consisted of 30 compare with control treatment in Figure 5 ). Thus, the min consecutive exposures to 0.1, 1, 10, and 100 nM melatonin.
SCN of wild-type mice exhibit a daily sensitivity to the Because of the large negative slope of multiunit activity at this time phase-shifting effects of melatonin in vitro, similar to (see Figure 3) , the effects of melatonin application on firing rate were that found in rats (McArthur et al., 1997) . Consequently, assessed relative to a separate group of slices for each genotype, to the in vitro single-unit assay is a valid method for aswhich vehicle was applied at the identical time. The genotype of the animals was not known until after experiments were completed sessing molecular mechanisms involved in melatoninand data were analyzed. Each value is the mean Ϯ SEM of 7-11 induced phase shifts in wild-type and receptor-deficient slices for each genotype at each melatonin dose.
mice. It is important to note that melatonin-induced phase shifts are not apparent with the multiunit assay, because of the broad firing-rate peak which occurs with assay provides a reliable method for assessing the acute suppressive effect of melatonin on neuronal firing in multiunit recordings (compare multiunit and single unit activity peaks in Figures 3 and 5, respectively) . Since SCN slices. the Mel 1a Receptor (Ϫ/Ϫ) mice, respectively, exposed to vehicle from CT 9.5-10.5 (open (A) Phase-shifting effect of 10 pM or 1 nM 2-iodomelatonin on the vertical bars). The lower panel shows the firing rate rhythm of an SCN electrical activity rhythm in wild-type (ϩ/ϩ) and homozygous SCN slice from a homozygous mutant mouse exposed to melatonin mutant (Ϫ/Ϫ) mice. SCN slices were treated with either vehicle (con-(1 nM) from CT 9.5-10.5 (hatched vertical bar), which resulted in a trol) or 2-iodomelatonin from CT 9.5-10.5, and the peak of the firing ‫4ف‬ hr phase advance in the firing rate rhythm. The dotted vertical rate rhythm was assessed (in CT) on the next day. The genotype of line represents the average time of peak electrical activity, used as the animals was not known until after experiments were completed. a phase reference point. Data are representative of three studies Bars represent mean Ϯ SEM. *, p Ͻ 0.01, Student's t test. per treatment. Arrows indicate time of slice preparation. The dark (B) Phase-shift data in (A) replotted to depict actual phase change period of the light-dark cycle in the animal room is indicated by the (phase advance) from control treatment. All phase shifts were signifihatched horizontal bars at the top of each panel.
cant (p Ͻ 0.01, Dunnett's test).
Mel1a receptor-deficient mice, we expected that targeted that were not significantly different in magnitude bedisruption of the Mel 1a receptor would abolish the phasetween wild types (3.6 Ϯ 0.1 hr; n ϭ 3) and receptorshifting effects of melatonin on SCN slices as monitored deficient mice (4.4 Ϯ 0.4 hr; n ϭ 6; p Ͼ 0.05, Student's with the single-unit assay. t test; Figure 6 ). Remarkably, however, the SCN from mice with tarWe next examined the response to a lower concentrageted disruption of the Mel 1a receptor still exhibited rotion of 2-iodomelatonin, to determine whether a contribust phase shifts to both melatonin and the melatonin bution of the Mel1a receptor to the phase-shifting effect agonist, 2-iodomelatonin. Melatonin (1 nM) applied from might be evident at a lower concentration. Indeed, when CT 9.5-10.5 to SCN slices from Mel 1a receptor-deficient 10 pM 2-iodomelatonin was applied, a clear difference mice produced a clear ‫4ف‬ hr phase advance in the elecin the magnitude of the phase shift was seen between trical activity rhythm peak, compared to control treatwild-type and Mel 1a receptor-deficient animals ( Figure  ment (Figure 5 ). In addition, the phase-shifting effects 6). While 10 pM 2-iodomelatonin elicited significant of 1 nM melatonin were indistinguishable between wildphase shifts in both wild-type and Mel 1a receptor null type and null mutant mice (data not shown). 2-Iodomelamutant mice (p Ͻ 0.01 for each genotype versus vehicletreated animals, Dunnett's test), the magnitude of the tonin at 1 nM also produced large ‫4ف(‬ hr) phase shifts RNA extracted from neonatal SCN was subjected to RT-PCR using specific primers for the Mel 1b melatonin receptor. PCR products were electrophoresed and blotted onto GeneScreen. Blots were hybridized with radiolabeled oligonucleotide probes specific for a sequence of the amplified fragment between the primers. A hybridizing band at 367 bp was detected. No hybridizing bands were detected when template was excluded from the PCR reactions. The Mel 1b receptor gene was also expressed in SCN of wild-type mice (data not shown). A similar pattern of expression was observed in a replicate experiment.
phase shift in receptor-deficient mice (2.0 Ϯ 0.4 hr; n ϭ intracellular signaling. Since the Mel1b melatonin receptor signals through Gi, pertussis toxin should block mela-4) was significantly smaller than that of wild-type mice (3.4 Ϯ 0.2 hr; n ϭ 5; p Ͻ 0.01, Student's t test). These tonin-induced phase shifts in Mel1a receptor-deficient mice. results show that the Mel1a melatonin receptor is not necessary for the phase-shifting effects of melatonin on Indeed, pertussis toxin-pretreatment blocked that ability of melatonin to phase shift the SCN electrical the SCN firing-rate rhythm, but the Mel 1a subtype does contribute to the response as revealed by low 2-iodoactivity rhythm in Mel 1a receptor-deficient mice. In SCN slices subjected to a 5 hr static bath of normal media melatonin concentrations. before treatment, 1 nM melatonin applied at CT 9.5-10.5 still elicited a 3.2 Ϯ 0.1 hr (n ϭ 3) phase advance in The Mel 1b Melatonin Receptor Is Expressed in Mouse SCN and May Participate circadian phase ( Figure 7A ). However, when SCN slices were preincubated with pertussis toxin (1 g/ml) for the in Phase-Shifting Activities Because melatonin elicits a high affinity phase-shift re-5 hr before the 1 nM melatonin treatment, the phase of the firing rhythm peak was not shifted (CT of activity sponse in SCN slices from Mel1a receptor-deficient mice, we postulate that melatonin-induced phase shifting in peak was 6.6 Ϯ 0.1 hr; n ϭ 3; Figure 7A ); that is, it was similar to the circadian phase of slices treated with the Mel1a knockout mice is mediated by the other high affinity melatonin receptor identified in mammals, the vehicle (CT of 6.9 Ϯ 0.2 hr; see Figure 6 ). Thus, a pertussis toxin-sensitive mechanism mediates the phaseMel1b melatonin receptor . To further explore participation of the Mel1b receptor in phaseshifting effects of melatonin in Mel1a receptor-deficient mice. shifting activities in Mel 1a receptor-deficient mice, we examined the effects of pertussis toxin on melatoninIf the Mel 1b receptor is involved in phase-shifting activities, then it must be present in mouse SCN. Expression induced phase shifts in these receptor-deficient mice. Pertussis toxin ADP-ribosylates the alpha subunit of G i , of the Mel 1b receptor gene was therefore examined by RT-PCR of mRNA from punches of SCN from wild-type G o , and G q , rendering these G proteins incapable of and Mel1a receptor-deficient mice. RT-PCR was used in SCN by in situ hybridization (Karschin et al., 1994) . Moreover, two calcium-independent potassium currents because Mel1b receptor transcripts in humans and rats (a rapidly activating type of outward rectifier potassium are expressed at levels below the limits of sensitivity of current and a transient A-current) have been found in standard in situ hybridization methods (Reppert et al., all neurons examined in rat SCN (Bouskila and Dudek, 1995) . We have isolated and sequenced the two exons 1995). By revealing that a G protein-coupled receptor of the mouse Mel 1b receptor gene that encode the coding mediates melatonin-induced inhibition of SCN neuronal region (unpublished data; see also Weaver et al., 1996) . firing, our Mel1a receptor knockout studies define a new This information allowed us to design PCR primers to potential mechanism of melatonin action on SCN function. amplify cDNA across the intron splice sites in the first
We propose that the acute inhibitory effect of melatocytoplasmic loop . The RT-PCR nin on the SCN circadian clock is of substantial physioresults showed that the Mel1b receptor is expressed in logical significance. By inhibiting SCN neurons, melatothe SCN of null mutant mice ( Figure 7B) . nin would help define neuronal sensitivity (set the gain) to phase-shifting stimuli. Since melatonin levels in mammals are elevated only at night (Klein, 1993) , it is likely Discussion that this is the time when the inhibitory effect occurs. Thus, the nighttime elevation of melatonin may normally The results provide molecular insights into the actions function to decrease the responsiveness of the SCN to of melatonin on the biological clock. Our studies reveal extraneous phase-shifting stimuli (e.g., activity-induced two distinct effects of melatonin on SCN physiology: an transmitter release). Light, on the other hand, appears acute inhibitory effect on neuronal firing and a phaseto have a "privileged" role in phase-shifting at night, shifting effect. We show that the Mel 1a melatonin recepbecause light exposure at night would not only initiate tor is necessary for the acute inhibitory action, providing glutamate neurotransmission in the SCN (Ding et al., a solid molecular basis for a heretofore poorly defined 1994), but also acutely inhibit nighttime melatonin levels, effect of melatonin on the biological clock (see below).
causing circulating melatonin levels to fall precipitously The phase shifting effect, on the other hand, is only (Klein, 1993) . By removing the inhibitory effect of melatomodestly altered in Mel 1a receptor-deficient mice. This is nin on SCN neuronal activity, continued light exposure a striking finding and indicates that another high affinity is actually potentiating its own effectiveness at night, at melatonin receptor must also be involved in the phasea time of the circadian cycle when the circadian clock shifting response to melatonin. Below, each of the two is most responsive to light's phase-shifting activities. In effects of melatonin on SCN function is addressed in fact, there is experimental evidence supporting a role light of our new findings.
for melatonin in suppressing phase shifts at night. A Our results show an acute inhibitory action of melatopreliminary study in mice shows that melatonin adminisnin on SCN multiunit activity at physiological levels of tration significantly attenuates the phase-delaying effect melatonin. Most other studies that have examined melaof a light-pulse applied during subjective night (Dubotonin-induced inhibitory effects on SCN neuronal firing covich et al., 1996); phase-advance effects of light were have been performed with single-unit extracellular renot examined. Further study of the gain-setting action cording, using either iontophoretically applied melatonin of melatonin on SCN neurons is clearly warranted. or pharmacological doses of melatonin added to the A startling aspect of the work reported here is our culture bath (Mason and Brooks, 1988; Shibata et al., finding that the Mel 1a receptor is not essential for the 1989; Stehle et al., 1989) . In contrast, our study with phase-shifting effect of melatonin in mice. All previous multiunit recording shows a very consistent, robust inlines of evidence pointed directly to the Mel 1a subtype hibitory response using physiological melatonin conas the mediator of the phase-shifting effect of melatonin. centrations (EC 50 of the response is 412 pM). An advanNonetheless, we now show that 1 nM concentrations of tage of our system is that it measures an integrated either melatonin or 2-iodomelatonin elicit large phase response from many neurons, and thus inhibitory effects shifts of similar magnitude in SCN electrical activity of melatonin on a restricted population of SCN neurons rhythms in both wild-type and Mel 1a receptor-deficient may be more easily and consistently detected with mice. There are two alternative models that might exmultiunit recordings. By exploiting the multiunit assay plain these data (Figure 8 ). The first and most plausible in Mel 1a receptor-deficient mice, we have discovered explanation is that the Mel 1a receptor normally mediates that an acute inhibitory effect of melatonin on SCN activvirtually all of the phase shifting effects of melatonin; ity is mediated through the Mel 1a melatonin receptor.
but when the receptor is eliminated, the phase shiftingThe Mel 1a receptor-mediated inhibition of neuronal effects of another receptor, which normally contributes firing is likely due to activation of potassium channels.
little to the phase-shifting response, is unmasked. A Whole-cell voltage-clamp studies have shown that melsecond, more heretical possibility is that the Mel 1a recepatonin can activate potassium conductances in rat SCN tor normally only mediates a small portion of the melato- (Jiang et al., 1995) . Potassium channels are activated nin signaling involved in phase shifts, and a second by the ␤␥ subunits of pertussis toxin-sensitive G proteins high affinity receptor primarily mediates phase-shifting (Wickman and Clapham, 1995) , consistent with Mel 1a responses to melatonin. It is also possible that a low signaling through G i . The recombilevel of either melatonin receptor is sufficient for the nant human Mel 1a receptor also activates heteromeric phase-shifting response. Regardless of which alternaKir3.1/3.2 potassium channels when expressed in Xenotive is operable, the results show that at least two differpus oocytes (Nelson et al., 1996) , and expression of ent receptors can mediate the phase-shifting effect of melatonin in the mouse SCN. Kir3.1 and Kir3.2 channel subunits has been detected Davis, 1993) . Again, the implication is that the Mel1a receptor is the only functional receptor in the Syrian hamster capable of mediating the phase-shifting response to melatonin in the developing SCN. In contrast to hamsters, the mouse Mel 1b receptor appears to be functional (i.e., there are no nonsense mutations in the coding region; unpublished data), and thus, in both mouse and human, a functional Mel 1b receptor could participate in circadian phase-shifting activities. It is important to add that with the substantial species differences in which melatonin receptor genes encode functional receptors (Mel1a receptor only or both Mel1a and Mel1b receptors), the mouse is most like the human, making the mouse SCN a model system that may closely mimic SCN function in humans.
If, as we propose, the Mel1b receptor is mediating melatonin-induced phase shifts in mice with targeted deletion of the Mel 1a receptor, then the lack of detectable 125 I-Mel binding means that only a minuscule number of high affinity receptors are needed to elicit a near-maximal phase-shifting response. This lack of a correlation between detectable 125 I-Mel binding and a functional response to melatonin is not unique to the mouse SCN. In cerebral and tail arteries, melatonin also elicits a high affinity response (vasoconstriction) without evidence of 125 I-Mel binding in mouse vessels by conventional in vitro autoradiography (C. Mahle, personal communication). Only further studies in mice with targeted deletion of the Mel1b receptor, and in mice with deletion of both the Mel 1a and Mel 1b receptors, will define the actual contribu- Our results suggest that the cellular mechanisms involved in the acute inhibitory and phase-shifting effects The receptor involved in melatonin-induced phase of melatonin are distinct. Even though the acute supshifting in Mel1a receptor-deficient mice appears to be pressive effect of melatonin on SCN multiunit firing at CT a high affinity, G protein-coupled receptor. Since the 9.5-11.5 is abolished in Mel1a receptor-deficient mice, only other high affinity melatonin receptor cloned from melatonin can still elicit large phase shifts at this time. mammals is the Mel1b receptor, which is expressed in Thus, the acute activation of potassium channels, which mouse SCN (Figure 7) , the Mel 1b subtype becomes the has been implicated in serotonin-induced phase shifts prime candidate for the receptor mediating circadian in rat SCN (Prosser et al., 1994) , appears not to be phase shifting in Mel 1a receptor-deficient mice. Curiinvolved in a substantial way in the melatonin-induced ously, the Mel 1b receptor is nonfunctional in Siberian and phase-shifting mechanism in mouse SCN. Although the Syrian hamsters ; our unpublished precise signal transduction cascade mediating melatodata); in both species, there are nonsense mutations in nin-induced phase shifting in mammalian SCN has not the region of the receptors encoded by the second exon.
been clearly delineated, studies in rats have suggested In the Siberian hamster, the Mel 1a receptor is functional, the involvement of protein kinase C (McArthur et al., and melatonin elicits clear phase-shifting effects on the 1997) and nitric oxide (Starkey, 1996) . Further elucida-SCN electrical activity rhythm . The tion of the receptors involved in melatonin-induced implication is that the Mel1a receptor is the only funcphase shifts in mouse SCN should help clarify the intrational high affinity melatonin receptor in the Siberian cellular signaling cascades important for the receptorhamster capable of mediating the phase-shifting remediated effects. sponse. In the Syrian hamster, in vivo administration of In summary, the results present a solid molecular melatonin entrains circadian rhythms only in fetal and basis for two distinct effects of melatonin on SCN funcneonatal hamsters (Davis and Mannion, 1988 ; Grosse tion. Further elucidation of the cellular and molecular et al., 1996) , not in adults (Hastings et al, 1992) . This mechanisms involved in these actions of melatonin developmental alteration in melatonin responsiveness should provide a firm foundation for understanding how is paralleled by a developmental decrease in 125 I-Mel this hormone influences circadian function. That melatonin can acutely suppress SCN neuronal activity adds a binding in the SCN with increasing age (Duncan and RT reaction. The histone H3.3 primers were 5Ј-GCAAGAGTGCGCCC TCTACTG-3Ј and 5Ј-GGCCTCACTTGCCTCCTGCAA-3Ј and amplify a band of 217 bp.
Experimental Procedures
After PCR, the reaction products were subjected to electrophoresis through a 1.5% agarose gel and blotted onto GeneScreen (New Construction of the Mel1a Receptor Targeting Vector England Nuclear). Blots were hybridized with 25-mer oligonucleo-A 15 kb genomic clone encoding part of the Mel1a receptor was tides, labeled with [␥-32 P]ATP by T4 polynucleotide kinase. For each isolated from a mouse 129/Sv genomic library (Stratagene) using a primer pair, the oligonucleotide probes were specific for a sequence probe generated from exon 1. The genomic clone contains ‫5.11ف‬ of the amplified fragment between the primers. Oligonucleotide sekb 5Ј of exon 1, exon 1 (0.6 kb, containing the translation start codon quences were 5Ј-TCATAGTACCACCTACCACCGGGTC-3Ј for the and encoding amino acids up to the first intracellular loop), and Mel1b receptor; and 5Ј-CACTGAACTTCTGATCCGCAAGCTC-3Ј for ‫5.3ف‬ kb of the large intron that separates the two exons (see Figure  histone H3 .3. Hybridizing conditions were 45ЊC overnight in 0.5 M 1). The entire genomic clone was subcloned into the NotI site of NaPO4 (pH 7.2), 7% SDS, 1% BSA, and 1 mM EDTA. The blots were pBluescript (Stratagene). The first exon was subsequently removed washed twice in 0.2 M NaP04, 1% SDS, and 1 mM EDTA at 45ЊC by restriction digestion with StuI and Eco47III. SalI adapters were for 30 min. ligated to the blunt ends to allow PGKNeo (digested with XhoI-SalI) to be inserted in place of receptor exon 1. The 15 kb insert of the targeting vector, containing PGKNeo, was then excised from the 125 I-Mel In Vitro Autoradiography plasmid with NotI and used for electroporation of J1 ES cells as Male mice were housed in ventilated environmental compartments previously described (Li et al., 1992) . Of 220 G418-resistant ES with a light:dark (LD) schedule of 12:12. Animals were killed by clones isolated, 27 contain the targeted allele based on Southern decapitation in the afternoon, 3-5 hr before lights-off, at 4-7 weeks blots of genomic DNA, digested with either EcoRV or SpeI and of age. Brains were removed, frozen in cooled (Ϫ20ЊC) 2-methylprobed with a 3Ј flanking probe not contained within the genomic butane, and stored at Ϫ80ЊC until sectioning in a Bright-Hacker clone.
cryostat. Fifteen micron coronal sections were collected as a 1-in-8 series Generation of Mel 1a Receptor-Deficient Mice throughout the entire brain from three wild-type, two heterozygous, Two targeted ES clones (25 and 68) were injected into C57BL/6 and two homozygous mutant mice. Sections encompassing the blastocysts as described (Bradley, 1987) to generate chimeras. Chihypothalamus were collected from an additional one wild-type, eight meric males were bred to C57BL/6 females, and germline transmisheterozygous, and three homozygous mutant mice. All tissue secsion of the mutant allele was detected by Southern blot analysis or tions were processed for 125 I-Mel binding in a single run. One series PCR (see Figure 1 ) of tail DNA (prepared as described by Laird et (sections at 120 m intervals) from each animal was processed for al., 1991) from F1 offspring with agouti coat color (representing total 125 I-Mel binding (100 pM 125 I-Mel), and an adjacent series of germline transmission of the ES genome). Germline transmission sections was processed for nonspecific binding (100 pM 125 I-Mel in was obtained from both clones. Offspring of heterozygous crosses the presence of 1 M melatonin). The ligand concentration of 100 were genotyped by Southern blotting or PCR (Figure 1) . pM was used to improve the chances of detection of binding to the Mel 1b receptor, which may have a lower affinity (KD ϭ 160 pM for the human clone). The autoradiographic procedure was exactly as Genotyping by Southern Blot Analysis previously described . Briefly, sections were Genomic DNA was digested with either EcoRV or SpeI and sepapreincubated in autoradiography buffer (50 mM Tris-HCl and 4 mM rated by electrophoresis through a 0.8% agarose gel. DNA was MgCl2, containing 0.1% BSA) for 1 hr at room temperature, incubated alkaline denatured and transferred to GeneScreen plus membrane in buffer with 100 pM 125 I-Mel (Ϯ 1 M melatonin), washed in ice-(Dupont/NEN) by capillary action. Membranes were hybridized with cold autoradiography buffer minus BSA (2 times for 15 min), dipped a PCR-generated 1.0 kb DNA fragment 3Ј of the targeted DNA (see in ice-cold distilled water, and then blown dry with a stream of cool Figure 1 ) labeled with [␣- 32 P]dCTP (2000 Ci/mmol) by random primair. Sections were apposed to Kodak BioMax MR film for 19 days. ing. Blots were washed with 0.2ϫ SSC and 0.1% SDS at 65ЊC.
Quantitative analysis of autoradiograms was performed using a computer-based image analysis system and the NIH Image proGenotyping by PCR Analysis gram. Radioactivity levels were determined by comparison to 125 IGenomic DNA was subjected to 35 cycles of amplification using microscale standards (Amersham) exposed along with the sections incubations at 94ЊC for 45 s, 60ЊC for 45 s, and 72ЊC for 3 min. The on each film. amplified DNA was separated on an agarose gel. The primers used for genotyping (position of primers shown in Figure 1) were: (A) 5Ј-GAGTCCAAGTTGCTGGGCAGTGGA-3Ј, (B) 5Ј-GAAGTTTTCTCA SCN Multiunit Recordings GTGTCCCGCAATGG-3Ј, and (C) 5Ј-CCAGCTCATTCCTCCACTCAT Adult male wild-type and homozygous mutant mice were housed GATCTA-3Ј.
in LD 12:12 for a minimum of 3 weeks prior to experimentation. After the adaptation period, the mice were killed 2.0-4.5 hr after lightson, and brains were rapidly dissected and placed into ACSF medium RT-PCR Analysis An RT-PCR assay was performed using a modification of a precontaining (in mM) NaCl (116.3), KCl (5.4), NaH2PO4 (1.0), NaHCO3 (26.2), CaCl2 (1.8), MgSO4 (0.8), dextrose (24.6), and 5 mg/l Gentamiviously described procedure (Kelly et al., 1993) . SCN were obtained from 1-week-old mice. Cylindrical punches of unilateral SCN were cin sulphate (pH 7.5).
A block of tissue containing the hypothalamus was dissected made from 400 m coronal sections, using a 20 gauge needle. Total RNA was extracted from a batch of SCN punches from the same from the brain and transferred to a manual tissue chopper, where coronal hypothalamic brain slices (400 m in thickness) containing genotype (four to nine animals per batch) using an Ultraspec RNA Isolation System (Biotecx Labs). Total RNA ‫2ف(‬ g) from SCN of the SCN were prepared. Slices were placed in a Haas-type brain slice chamber (Haas et al., 1979 ; Medical Systems Corporation), wild-type or homozygous mutant mice was primed with random hexamers and reverse transcribed as previously described (Reppert and gauze strips were placed over the slices in the vicinity of the SCN to raise the fluid level above the slices. They were continually et al., 1994). The cDNA was subjected to 25 cycles of amplification with 200 nM each of two specific primers. PCR conditions were superfused with ACSF medium warmed to 37ЊC.
To record multiple-unit SCN electrical activity, a 76 m diameter, 94ЊC for 45 s, 60ЊC for 45 s, and 72ЊC for 2 min. The Mel 1b receptorspecific primers were designed to amplify cDNA across the intron teflon-coated, platinum-iridium wire electrode was lowered into the brain slice in the SCN (Bouskila and Dudek, 1993). This electrical splice sites in the first cytoplasmic loop. Since the intron is ‫9ف‬ kb,
